Chainalysis: Gray-market peptide suppliers accelerate shift to Bitcoin and stablecoins, with Q1 crypto inflows surging 159% year-on-year
According to The Block, blockchain analytics firm Chainalysis’ latest report states that as the gray-market peptide industry’s scale exceeds an annualized $100 million, leading suppliers are accelerating adoption of Bitcoin and stablecoins as primary settlement instruments. In Q1 2026, cryptocurrency inflows into this industry reached $32 million—a 159% quarter-on-quarter surge. Due to widespread bans imposed by traditional banks and credit card payment channels on prescription-grade compounds and unregulated substances, numerous Chinese chemical manufacturers have turned to cryptocurrencies for transactions, with high-value orders especially favoring stablecoins to hedge against price volatility risk.
